WO2009108067A3 - Prévention et traitement de l’inflammation hsmi - Google Patents

Prévention et traitement de l’inflammation hsmi Download PDF

Info

Publication number
WO2009108067A3
WO2009108067A3 PCT/NO2009/000069 NO2009000069W WO2009108067A3 WO 2009108067 A3 WO2009108067 A3 WO 2009108067A3 NO 2009000069 W NO2009000069 W NO 2009000069W WO 2009108067 A3 WO2009108067 A3 WO 2009108067A3
Authority
WO
WIPO (PCT)
Prior art keywords
hsmi
prevention
treatment
fatty acid
acid derivatives
Prior art date
Application number
PCT/NO2009/000069
Other languages
English (en)
Other versions
WO2009108067A2 (fr
Inventor
Kjell-Arne RØRVIK
Henriette Alne
Magny Thomassen
Rolf Kristian Berge
Original Assignee
Thia Medica As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thia Medica As filed Critical Thia Medica As
Priority to EP09714090A priority Critical patent/EP2257282A2/fr
Publication of WO2009108067A2 publication Critical patent/WO2009108067A2/fr
Publication of WO2009108067A3 publication Critical patent/WO2009108067A3/fr
Priority to NO20101223A priority patent/NO20101223L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Insects & Arthropods (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Birds (AREA)
  • Neurology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne l’utilisation d’un composé dans la préparation d’une composition nutritionnelle et/ou pharmaceutique destinée à réduire la mortalité associée à l’inflammation HSMI (inflammation du cœur et des muscles squelettiques) chez le poisson.
PCT/NO2009/000069 2008-02-27 2009-02-27 Prévention et traitement de l’inflammation hsmi WO2009108067A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP09714090A EP2257282A2 (fr) 2008-02-27 2009-02-27 Prévention et traitement de l inflammation hsmi
NO20101223A NO20101223L (no) 2008-02-27 2010-09-02 Prevention and treatment of HSMI

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO20081040A NO20081040L (no) 2008-02-27 2008-02-27 Reduced HSMI mortality
NO20081040 2008-02-27

Publications (2)

Publication Number Publication Date
WO2009108067A2 WO2009108067A2 (fr) 2009-09-03
WO2009108067A3 true WO2009108067A3 (fr) 2009-11-12

Family

ID=41003478

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/NO2009/000069 WO2009108067A2 (fr) 2008-02-27 2009-02-27 Prévention et traitement de l’inflammation hsmi

Country Status (4)

Country Link
EP (1) EP2257282A2 (fr)
CL (1) CL2009000460A1 (fr)
NO (2) NO20081040L (fr)
WO (1) WO2009108067A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO341929B1 (no) * 2009-09-14 2018-02-19 Chemoforma Ltd Fôrsammensetning
NO347765B1 (no) * 2012-11-01 2024-03-18 Ewos Innovation As Fôrsammensetning for fisk

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005121325A1 (fr) * 2004-06-11 2005-12-22 Pharmaq As Virus (hsmi) d'inflammation musculaire squelettique et cardiaque
WO2006009464A2 (fr) * 2004-07-19 2006-01-26 Thia Medica As Composition comprenant des huiles vegetales et/ou de poisson et composes comprenant des entites d'acide gras non oxydables
WO2007061314A2 (fr) * 2005-11-23 2007-05-31 Berge Biomed As Utilisation d'analogues d'acides gras

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005121325A1 (fr) * 2004-06-11 2005-12-22 Pharmaq As Virus (hsmi) d'inflammation musculaire squelettique et cardiaque
WO2006009464A2 (fr) * 2004-07-19 2006-01-26 Thia Medica As Composition comprenant des huiles vegetales et/ou de poisson et composes comprenant des entites d'acide gras non oxydables
WO2007061314A2 (fr) * 2005-11-23 2007-05-31 Berge Biomed As Utilisation d'analogues d'acides gras

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
K-A RØRVIK ET AL.: "Increased survival by feeding tetradecylthioacetic acid during a natural outbreak of heart and skeletal muscle inflammation in S0 Atlantic salmon, Salmo salar L.", JOURNAL OF FISH DISEASES, 10 July 2009 (2009-07-10), pages 1 - 9, XP002543693, Retrieved from the Internet <URL:http://www3.interscience.wiley.com/journal/122508190/abstract?CRETRY=1&SRETRY=0> [retrieved on 20090901] *

Also Published As

Publication number Publication date
NO20101223L (no) 2010-09-02
NO20081040L (no) 2009-08-28
WO2009108067A2 (fr) 2009-09-03
EP2257282A2 (fr) 2010-12-08
CL2009000460A1 (es) 2010-02-05

Similar Documents

Publication Publication Date Title
WO2011056487A3 (fr) Formulations stables d&#39;épaississant
NZ618734A (en) Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas
WO2009007412A3 (fr) Deglycation des ages
WO2012074930A3 (fr) Composition à faible éructation et méthodes de traitement et/ou de prévention de maladie cardiovasculaire chez un sujet présentant une allergie/hypersensibilité aux poissons
ZA200903862B (en) Nutritional supplement composition for treatment of ocular diseases
WO2011118976A3 (fr) Composition pharmaceutique pour la prévention ou le traitement d&#39;une stéatose hépatique non alcoolique et procédé pour la prévention ou le traitement de la stéatose hépatique non alcoolique utilisant celle-ci
MY159379A (en) Composition for human and/or animal nutrition, uses thereof and yeasts
EP3228311A3 (fr) Compositions pharmaceutiques et nutritionnelles de l&#39;acide abscisique
EP2036565A4 (fr) Préparation pour application cutanée contenant de l&#39;acide triterpénique
WO2013028555A3 (fr) Procédés pour la perte de poids et compositions cétogènes
MY159492A (en) Solid pharmaceutical formulation with delayed release
GEP20125464B (en) Dha esters and use thereof in treatment and prevention of cardiovascular disease
WO2010087565A3 (fr) Nouvelle utilisation de la pipérine
TW200621732A (en) Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals
WO2011077163A3 (fr) Utilisation
ZA201003764B (en) Mixed butyric-formic esters of acid polysaccharides, and their preparation and use as skin cosmetics
WO2006109194A3 (fr) Composes de chrome et d&#39;acides gras et leurs procedes de fabrication et d&#39;utilisation
WO2007107008A8 (fr) Composés et compositions utilisables pour la prévention et le traitement de troubles du métabolisme lipidique et de l&#39;obésité
WO2011031166A3 (fr) Composition d&#39;aliment
WO2012064159A3 (fr) Composition anticancéreuse
WO2009061152A3 (fr) Composition pour la prévention et le traitement de la douleur contenant de la curcumine ou un sel pharmaceutiquement acceptable de celle-ci comme ingrédient actif
WO2009108067A3 (fr) Prévention et traitement de l’inflammation hsmi
WO2011118957A3 (fr) Composition destinée à traiter les maladies inflammatoires, allergiques ou asthmatiques contenant des extraits de paprika
WO2011143271A3 (fr) Liposomes thérapeutiques et leurs procédés de production et d&#39;utilisation
WO2008116737A3 (fr) Capsules contenant des préparations végétales

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09714090

Country of ref document: EP

Kind code of ref document: A2

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2009714090

Country of ref document: EP